Dialysis News and Research

Latest Dialysis News and Research

Texas Senators higlight CMS about the delay in opening many local dialysis facilities

As Congress prepares to reconvene next week following an August recess period filled with wide-ranging local discussion of health care reform, the Texas kidney community expressed hope that the momentum and public desire for health care reform in Washington can help drive momentum and discussion in Texas about the vital need to open 38 end stage renal disease (ESRD) centers still sitting idle, which, if opened, will dramatically expand access to quality dialysis care and create good-paying local jobs.

5 Sep 2009

Real American Brands to start medical transportation business

Real American Brands, Inc. (PINKSHEETS: RLAB) announced today that the company has approved plans to pursue and operate an emergency and non-emergency health services transportation division, to be developed in close consultation with transport and medical personnel who have broad experience in the field.

4 Sep 2009

Medicare advantage rates could go up, while Part D 'exceeding expectations'

"Despite near-zero inflation and recessionary conditions, health insurers in 2010 face another year of double-digit increases in the charges they pay for hospital services, physicians, drugs, and other healthcare costs," U.S. News and World Report writes in a news column.

4 Sep 2009

Beijing Rain and Earth Technology to provide cheaper blood dialysis in China

RainEarth Inc. (OTC Bulletin Board: RNER; "the Company") announced that in the second quarter of 2009, the Xinhua News Agency publicized the creation of "Opinions of the CPC Central Committee and the State Council on Deepening the Reform of the Medical and Health Care System" ("Opinion").

3 Sep 2009

Netherlands shows the way in healthcare accountability

As national healthcare reform initiatives grab headlines throughout the U.S., Maasstad Hospital in Rotterdam, The Netherlands, is quietly demonstrating how physicians, nurses, and administrators can be held accountable to national performance standards.

3 Sep 2009

Colorado braces for mental health cuts, Florida nursing homes brace for Medicare cuts, and other developments

Kaiser Health News: "Three years after Massachusetts implemented a state program to provide near universal health care, officials said that a key to their success was that stakeholders from the state's health care sector and the business community had a commitment to implementing the program." Despite successes, one state official said cost containment remains a challenge (Marcy, 9/1).

3 Sep 2009

Validus chooses Ranbaxy to market an authorized generic version of Rocaltrol in the US

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with Validus Pharmaceuticals LLC (Validus) to market and distribute an authorized generic version of Rocaltrol(R) (calcitriol) in both softgel capsules and an oral liquid formulation. Overall market sales for calcitriol softgel capsules and oral liquid were $70 million (IMS - MAT: June 2009).

2 Sep 2009

The Kyoto Heart study shows positive effect of valsartan on cardiovascular outcome

The KYOTO HEART Study, which took place in Japan between January 2004 and January 2009, shows that the addition of valsartan to conventional antihypertensive treatment to improve blood pressure control is associated with an improved cardiovascular outcome in Japanese hypertensive patients at high risk of CVD events.

2 Sep 2009

PROTECT clinical study aimed at the assessment of rolofylline effects

Despite the promising findings of the PROTECT Pilot study, the larger PROTECT trial found no difference with rolofylline versus placebo with respect of the primary and main secondary end-points of the study. Although more rolofylline patients than placebo patients experienced moderate or marked dyspnea improvement at 24 and 48 hours from randomization, this was counterbalanced by a lack of effect on persistent renal impairment. Lastly, the risk of important neurological events was increased in patients on rolofylline.

2 Sep 2009

Study reveals that valsartan prevents cardiovascular events in high-risk hypertensive Japanese patients

2 Sep 2009

Study reveals that baking soda benefits patients with advanced chronic kidney disease

A daily dose of sodium bicarbonate—baking soda, already used for baking, cleaning, acid indigestion, sunburn, and more—slows the decline of kidney function in some patients with advanced chronic kidney disease (CKD), reports an upcoming study in the Journal of the American Society of Nephrology (JASN).

2 Sep 2009

Heart health of kidney disease patients not affected by dialysis treatment

Dialysis treatments do not affect the heart health of kidney disease patients who have had a heart attack, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Since cardiovascular disease is the most common cause of death in kidney disease patients, the findings are good news for individuals who need the treatments.

1 Sep 2009

Davita Chairman is one of 100 Most Powerful People in Healthcare

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced that Modern Healthcare Magazine, one of the nation's leading health care industry publications, named Kent Thiry, Chairman and CEO for DaVita(R), as one of the 100 Most Powerful People in Healthcare in 2009.

1 Sep 2009

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

28 Aug 2009

AgaMatrix educates health care professionals and patients on the importance of blood glucose meter accuracy

AgaMatrix, Inc., the makers of WaveSense blood glucose meters, announced today their continued commitment to educate health care professionals and patients on the importance of blood glucose meter (BGM) accuracy for all patients.

28 Aug 2009

Blood thinner warfarin may have opposite effects in kidney disease patients on dialysis

The blood thinner warfarin can prevent strokes in most individuals with abnormal heart rhythms, but the drug may have the opposite effect in kidney disease patients on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that warfarin should be prescribed with caution in patients with kidney failure.

27 Aug 2009

DaVita to present three abstracts on Peritoneal Dialysis at the ISPD meeting

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research(R), today announced that it will present three abstracts at the 3rd North American Chapter meeting of the International Society for Peritoneal Dialysis (ISPD) on August 27-29 in Vancouver, British Columbia.

26 Aug 2009

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

26 Aug 2009

Diplomat Specialty Pharmacy and Ohio Caresource collaborate to develop Chronic Kidney Disease treatment

Diplomat Specialty Pharmacy announced today that its Diplomat Health Services Division is partnering with CareSource in Ohio to slow the progression of Chronic Kidney Disease (CKD), improve clinical outcomes and reduce healthcare costs associated with the disease. As the number of Americans with CKD continues to rise, CareSource is focused on the early identification and treatment of their patients with the illness.

25 Aug 2009

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ: APCVZ), announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market penicillin G potassium for Injection, USP, in two dosage strengths. Penicillin G is therapeutically equivalent to the reference drug PfizerPen™ G, which is marketed by the innovator Pfizer, Inc.

25 Aug 2009

Dialysis News and Research

Latest Dialysis News and Research

Texas Senators higlight CMS about the delay in opening many local dialysis facilities

Real American Brands to start medical transportation business

Medicare advantage rates could go up, while Part D 'exceeding expectations'

Beijing Rain and Earth Technology to provide cheaper blood dialysis in China

Netherlands shows the way in healthcare accountability

Colorado braces for mental health cuts, Florida nursing homes brace for Medicare cuts, and other developments

Validus chooses Ranbaxy to market an authorized generic version of Rocaltrol in the US

The Kyoto Heart study shows positive effect of valsartan on cardiovascular outcome

PROTECT clinical study aimed at the assessment of rolofylline effects

Study reveals that valsartan prevents cardiovascular events in high-risk hypertensive Japanese patients

Study reveals that baking soda benefits patients with advanced chronic kidney disease

Heart health of kidney disease patients not affected by dialysis treatment

Davita Chairman is one of 100 Most Powerful People in Healthcare

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

AgaMatrix educates health care professionals and patients on the importance of blood glucose meter accuracy

Blood thinner warfarin may have opposite effects in kidney disease patients on dialysis

DaVita to present three abstracts on Peritoneal Dialysis at the ISPD meeting

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Diplomat Specialty Pharmacy and Ohio Caresource collaborate to develop Chronic Kidney Disease treatment

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Dialysis News and Research

Latest Dialysis News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in